Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Cardiovascular News

News
Out-of-Pocket Costs Make PCSK9 Inhibitors Inaccessible
09/29/2017
New research found that fewer than a third of patients whose doctors prescribe PCSK9 inhibitors get them.
New research found that fewer than a third of patients whose doctors prescribe PCSK9 inhibitors get them.
New research found that fewer...
09/29/2017
First Report Managed Care
News
Increased Risk of Heart Attack, Stroke Soon after Cancer Diagnosis
08/30/2017
Recent research examined the risk of heart attack and stroke in patients diagnosed with cancer.
Recent research examined the risk of heart attack and stroke in patients diagnosed with cancer.
Recent research examined the...
08/30/2017
Pharmacy Learning Network

Advertisement

News
Bivalirudin No Better Than Heparin Among MI Patients Getting PCI
08/28/2017
Researchers examined bleeding risk, myocardial infarction (MI), and death rates in patients with acute MI undergoing urgent PCI who replaced heparin with bivalirudin in a standard anticoagulant regimen.
Researchers examined bleeding risk, myocardial infarction (MI), and death rates in patients with acute MI undergoing urgent PCI who replaced heparin with bivalirudin in a standard anticoagulant regimen.
Researchers examined bleeding...
08/28/2017
Pharmacy Learning Network
News
Less bleeding after PCI when dabigatran replaces aspirin, warfarin in AFib
08/28/2017
Recent research assessed bleeding risk with dual or triple therapy after percutaneous coronary intervention in patients with atrial fibrillation.
Recent research assessed bleeding risk with dual or triple therapy after percutaneous coronary intervention in patients with atrial fibrillation.
Recent research assessed...
08/28/2017
Pharmacy Learning Network
News
New Data Boosts Case for Extended Use of AstraZeneca Heart Drug
08/24/2017
A recent study examined the risk of cardiovascular death in patients with a history of past myocardial infarction who took AstraZeneca's blood-thinner Brilinta (ticagrelor) beyond the standard 12-month initial period. 
A recent study examined the risk of cardiovascular death in patients with a history of past myocardial infarction who took AstraZeneca's blood-thinner Brilinta (ticagrelor) beyond the standard 12-month initial period. 
A recent study examined the risk...
08/24/2017
First Report Managed Care

Advertisement

News
Elderly Report Similar QOL With Invasive vs Conservative ACS Management
08/11/2017
Researchers compared invasive versus conservative approaches to acute coronary syndrome management in patients over age 80.
Researchers compared invasive versus conservative approaches to acute coronary syndrome management in patients over age 80.
Researchers compared invasive...
08/11/2017
Annals of Long-Term Care
News
How SGLT2 Inhibitors Impact CVD Risk in Diabetes Patients
08/10/2017
Recent research examined the effects of SGLT2 inhibitors on the risk of cardiovascular morbidity and mortality in patients with type 2 diabetes.
Recent research examined the effects of SGLT2 inhibitors on the risk of cardiovascular morbidity and mortality in patients with type 2 diabetes.
Recent research examined the...
08/10/2017
Pharmacy Learning Network
News
Intensifying Lipid-Lowering Therapy May Curb Need for PCSK9 Inhibitors
08/09/2017
Researchers revealed the cost-effective benefits of using oral lipid-lowering therapy in patients with atherosclerotic cardiovascular disease.
Researchers revealed the cost-effective benefits of using oral lipid-lowering therapy in patients with atherosclerotic cardiovascular disease.
Researchers revealed the...
08/09/2017
Pharmacy Learning Network

Advertisement

News
Blood Pressure Variability Linked to Dementia
08/07/2017
Daily blood pressure readings were examined in older adults without dementia to investigate the relationship of daily blood pressure to dementia development.
Daily blood pressure readings were examined in older adults without dementia to investigate the relationship of daily blood pressure to dementia development.
Daily blood pressure readings...
08/07/2017
Annals of Long-Term Care
News
Typical Adults Eat Enough Salt to Damage the Heart
08/02/2017
The amount of salt a typical American adult consumes each day may be enough to damage the heart muscle, a study suggests.
The amount of salt a typical American adult consumes each day may be enough to damage the heart muscle, a study suggests.
The amount of salt a typical...
08/02/2017
Pharmacy Learning Network

Advertisement

Advertisement

Advertisement

What's Trending?

eINTERACT: The Effect of Health Information Technology on Nurse-to-Provider Communication and Avoidable Hospital Transfers
09/16/2019
This quality improvement project incorporated eINTERACT clinical decision support tools into the electronic health record at two subacute rehabilitation centers in New Jersey in an effort to enhance nurse-to-provider communication and reduce...
This quality improvement project incorporated eINTERACT clinical decision support tools into the electronic health record at two subacute rehabilitation centers in New Jersey in an effort to enhance nurse-to-provider communication and reduce...
This quality improvement project...
09/16/2019
Annals of Long-Term Care
News
Narcotic Pain Reliever Recalled
04/20/2018
A prescription opioid analgesic used to treat moderate to severe pain is being recalled.
A prescription opioid analgesic used to treat moderate to severe pain is being recalled.
A prescription opioid analgesic...
04/20/2018
Pharmacy Learning Network
News
FDA Reviews Pregnancy and Pain Med Studies
01/12/2015
The FDA issued a safety announcement on January 9 regarding the use of prescription and over-the-counter pain medications in pregnant women.
The FDA issued a safety announcement on January 9 regarding the use of prescription and over-the-counter pain medications in pregnant women.
The FDA issued a safety...
01/12/2015
Pharmacy Learning Network
News
CVS Caremark Study Finds Value Based Insurance Designs Can Increase Adherence in Diabetes Patients
02/16/2010
02/16/2010
First Report Managed Care
News
FDA Targets Firms Illegally Selling Cannabidiol Products
11/27/2019
More than a dozen companies received warning letters from the US Food and Drug Administration about illegally selling products containing cannabidiol.
More than a dozen companies received warning letters from the US Food and Drug Administration about illegally selling products containing cannabidiol.
More than a dozen companies...
11/27/2019
Pharmacy Learning Network

Advertisement

Stay Informed—Sign up today!

Population Health Newsletter

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use